Current research on Genetic Syndrome and Gene Therapy

Image

Current research on Genetic Syndrome and Gene Therapy

The Journal of Genetic Syndromes & Gene Therapy aims to disseminate knowledge and promote discussion through the publication of peer-reviewed, high quality research papers on all topics related to genetics. On behalf of the Journal of Genetic Syndromes & Gene Therapy, as Editor-in-Chief, it is my great pleasure and honour to welcome you to the Journal of Genetic Syndromes & Gene Therapy.

Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis

The recent FDA approval of two drugs to treat the basic defect in cystic fibrosis has given hope to patients and their families battling this devastating disease. Over many years, with heavy financial investment from Vertex Pharmaceuticals and the Cystic Fibrosis Foundation, pre-clinical evaluation of thousands of synthetic drugs resulted in the production of Kalydeco and Orkambi. Yet, despite the success of this endeavor, many other compounds have been proposed as therapeutic agents in the treatment of CF. Of note, several of these compounds are naturally occurring, and are present in spices from the grocery store and over the counter preparations in health food stores. Inthis short review, we look at three such compounds, genistein, curcumin, and resveratrol, and evaluate the scientificsupport for their use as therapeutic agents in the treatment of patients with CF.The Scientists, Professors, Research scholars, Doctors can publish their high quality papers for worldwide viability on our online platform.https://www.longdom.org/genetic-syndromes-gene-therapy.html

This Genetics journal is using Editorial Tracking System for online manuscript submission. Manuscript can be submitted through online portal system https://www.longdom.org/submissions/genetic-syndromes-gene-therapy.html

The Journal is successfully running in the 10th Volume which covers a wide area of online platform. Genetic Syndromes & Gene Therapy is an official peer-reviewed journal for the rapid publication of innovative research covering all aspects of Gene Mapping and Gene Therapy. Genetic Syndromes, Gene Mapping & Gene Therapy with highest impact factor offers Open Access option to meet the needs of authors and maximize article visibility and creates a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.

Journal of Genetic Syndromes & Gene Therapy has NLM ID: 101574143 Index Copernicus Value 2016: 84.15, Journal Impact Factor 2.34*,  ISSN: 2157-7412.

Best Regards

Christiane zweier

Journal co-ordinator

Journal of Genetic Syndromes & Gene Therapy